Novocure (NVCR) Tops Q4 EPS by 19c ; Offers Guidance

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.22), $0.19 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $174.35 million versus the consensus estimate of $168.31 million.

GUIDANCE:

Novocure sees FY2026 revenue of $675-705 million, versus the consensus of $681.2 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities